|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Glycoprotein/peptide
|
 |
|
Title:
|
 |
Structures of three HIV-1 hla-b5703-peptide complexes and identification of related hlas potentially associated with long-term non-progression
|
|
Structure:
|
 |
Hla class i histocompatibility antigen, b-57 alpha chain. Chain: a. Fragment: residues 25-300. Synonym: mhc class i antigen b 57, Bw-57, hla-b5703. Engineered: yes. Beta-2-microglobulin. Chain: b. Fragment: residues 21-119. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 511693. Synthetic: yes. Human immunodeficiency virus. Organism_taxid: 12721
|
|
Biol. unit:
|
 |
Trimer (from PDB file)
|
|
Resolution:
|
 |
|
2.00Å
|
R-factor:
|
0.208
|
R-free:
|
0.267
|
|
|
Authors:
|
 |
G.B.Stewart-Jones,G.Gillespie,I.M.Overton,R.Kaul,P.Roche, A.J.Mcmichael,S.Rowland-Jones,E.Y.Jones
|
|
Key ref:
|
 |
G.B.Stewart-Jones
et al.
(2005).
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.
J Immunol,
175,
2459-2468.
PubMed id:
|
 |
|
Date:
|
 |
|
01-Jul-05
|
Release date:
|
07-Sep-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Immunol
175:2459-2468
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression.
|
|
G.B.Stewart-Jones,
G.Gillespie,
I.M.Overton,
R.Kaul,
P.Roche,
A.J.McMichael,
S.Rowland-Jones,
E.Y.Jones.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Long-term nonprogression during acute HIV infection has been strongly associated
with HLA-B*5701 or HLA-B*5703. In this study, we present the high resolution
crystal structures of HLA-B*5703 complexes with three HIV-1 epitopes: ISPRTLNAW
(ISP), KAFSPEVIPMF (KAF-11), and KAFSPEVI (KAF-8). These reveal peptide
anchoring at position 2 and their C termini. The different peptide lengths and
primary sequences are accommodated by variation in the specific contacts made to
the HLA-B*5703, flexibility in water structure, and conformational adjustment of
side chains within the peptide-binding groove. The peptides adopt markedly
different conformations, and trap variable numbers of water molecules, near a
cluster of tyrosine side chains located in the central region of the
peptide-binding groove. The KAF-11 epitope completely encompasses the shorter
KAF-8 epitope but the peptides are presented in different conformations; the
KAF-11 peptide arches out of the peptide-binding groove, exposing a significant
main chain surface area. Bioinformatic analysis of the MHC side chains observed
to contribute to the peptide anchor specificity, and other specific peptide
contacts, reveals HLA alleles associated with long-term nonprogression and a
number of related HLA alleles that may share overlapping peptide repertoires
with HLA-B*5703 and thus may display a similar capacity for efficient immune
control of HIV-1 infection.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Zhang,
W.Li,
L.Song,
and
L.Chen
(2010).
A towards-multidimensional screening approach to predict candidate genes of rheumatoid arthritis based on SNP, structural and functional annotations.
|
| |
BMC Med Genomics,
3,
38.
|
 |
|
|
|
|
 |
M.Lacerda,
K.Scheffler,
and
C.Seoighe
(2010).
Epitope discovery with phylogenetic hidden Markov models.
|
| |
Mol Biol Evol,
27,
1212-1220.
|
 |
|
|
|
|
 |
C.Bowman,
and
O.Delrieu
(2009).
Immunogenetics of drug-induced skin blistering disorders. Part II: synthesis.
|
| |
Pharmacogenomics,
10,
779-816.
|
 |
|
|
|
|
 |
J.Huang,
J.J.Goedert,
E.J.Sundberg,
T.D.Cung,
P.S.Burke,
M.P.Martin,
L.Preiss,
J.Lifson,
M.Lichterfeld,
M.Carrington,
and
X.G.Yu
(2009).
HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses.
|
| |
J Exp Med,
206,
2959-2966.
|
 |
|
|
|
|
 |
D.Chessman,
L.Kostenko,
T.Lethborg,
A.W.Purcell,
N.A.Williamson,
Z.Chen,
L.Kjer-Nielsen,
N.A.Mifsud,
B.D.Tait,
R.Holdsworth,
C.A.Almeida,
D.Nolan,
W.A.Macdonald,
J.K.Archbold,
A.D.Kellerher,
D.Marriott,
S.Mallal,
M.Bharadwaj,
J.Rossjohn,
and
J.McCluskey
(2008).
Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
|
| |
Immunity,
28,
822-832.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.O.Peters,
M.G.Mendoza,
R.E.Capina,
M.Luo,
X.Mao,
M.Gubbins,
N.J.Nagelkerke,
I.Macarthur,
B.B.Sheardown,
J.Kimani,
C.Wachihi,
S.Thavaneswaran,
and
F.A.Plummer
(2008).
An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort.
|
| |
J Virol,
82,
1980-1992.
|
 |
|
|
|
|
 |
J.Tang,
W.Shao,
Y.J.Yoo,
I.Brill,
J.Mulenga,
S.Allen,
E.Hunter,
and
R.A.Kaslow
(2008).
Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.
|
| |
J Immunol,
181,
2626-2635.
|
 |
|
|
|
|
 |
S.Gras,
L.Kjer-Nielsen,
S.R.Burrows,
J.McCluskey,
and
J.Rossjohn
(2008).
T-cell receptor bias and immunity.
|
| |
Curr Opin Immunol,
20,
119-125.
|
 |
|
|
|
|
 |
X.G.Yu,
M.Lichterfeld,
S.Chetty,
K.L.Williams,
S.K.Mui,
T.Miura,
N.Frahm,
M.E.Feeney,
Y.Tang,
F.Pereyra,
M.X.Labute,
K.Pfafferott,
A.Leslie,
H.Crawford,
R.Allgaier,
W.Hildebrand,
R.Kaslow,
C.Brander,
T.M.Allen,
E.S.Rosenberg,
P.Kiepiela,
M.Vajpayee,
P.A.Goepfert,
M.Altfeld,
P.J.Goulder,
and
B.D.Walker
(2007).
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.
|
| |
J Virol,
81,
1619-1631.
|
 |
|
|
|
|
 |
A.Lazaryan,
E.Lobashevsky,
J.Mulenga,
E.Karita,
S.Allen,
J.Tang,
and
R.A.Kaslow
(2006).
Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans.
|
| |
J Virol,
80,
6056-6060.
|
 |
|
|
|
|
 |
C.Pastori,
B.Weiser,
C.Barassi,
C.Uberti-Foppa,
S.Ghezzi,
R.Longhi,
G.Calori,
H.Burger,
K.Kemal,
G.Poli,
A.Lazzarin,
and
L.Lopalco
(2006).
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression.
|
| |
Blood,
107,
4825-4833.
|
 |
|
|
|
|
 |
E.J.Im,
J.P.Nkolola,
K.di Gleria,
A.J.McMichael,
and
T.Hanke
(2006).
Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques.
|
| |
Eur J Immunol,
36,
2574-2584.
|
 |
|
|
|
|
 |
S.R.Burrows,
J.Rossjohn,
and
J.McCluskey
(2006).
Have we cut ourselves too short in mapping CTL epitopes?
|
| |
Trends Immunol,
27,
11-16.
|
 |
|
|
|
|
 |
T.Blicher,
J.S.Kastrup,
L.Ã.˜.Pedersen,
S.Buus,
and
M.Gajhede
(2006).
Structure of HLA-A*1101 in complex with a hepatitis B peptide homologue.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
62,
1179-1184.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |